Teradyne and FormFactor jump after Jefferies starts coverage with Buy ratings

Jefferies initiated coverage of Teradyne and FormFactor with Buy ratings, citing their roles in AI-driven chip testing. Teradyne's stock rose 8.3% to $265.78, with a $284 target, while FormFactor gained 11.9% with a $102 target. Jefferies projects significant growth in the automated test equipment market, with Teradyne's revenue potentially rising from $1.9B to $6.9B by 2030. Both companies have seen recent pullbacks but reported strong AI-related revenue growth.

Original reporting
Published Nov 12, 2026, 2:01 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 3:57 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Teradyne and FormFactor jump after Jefferies starts coverage with Buy ratings — source image
Decision brief

The 30-second read

$TERBullishHigh
01

Why it matters

Analyst initiation drove immediate price spikes, indicating market sensitivity to coverage on niche AI supply chain players.

02

Market read

The article highlights fresh analyst buy ratings that moved both stocks sharply, offering a short‑term trading opportunity.

03

What to watch

Both companies lack confirmed Nvidia contracts; upside depends on future win rates.

Relevance 7/10Novelty 7/10Timing: pre-market today

Background

Jefferies launched new coverage on two AI‑related test equipment makers, citing growth in AI spend and potential Nvidia demand.

Company-level read

Ticker impact

$TERBullishHigh confidence
Context

Jefferies initiated coverage with a Buy rating and a $284 price target, sending TER up 8.3% intraday.

Expected impact

likely upward pressure as traders price in the new buy rating and target.

Evidence & confidence

The coverage is fresh, includes a target above current price, and triggered an 8% move.

$FORMBullishHigh confidence
Context

Jefferies also started coverage with a Buy rating and a $102 target, lifting FORM about 12% intraday.

Expected impact

likely upward pressure as investors absorb the fresh rating and perceived entry point.

Evidence & confidence

Coverage is first report and already moved the stock sharply.

Market effects

Boosts sentiment for the automated test equipment sector and AI‑related hardware supply chain.

U.S. tech equities may see modest gains as the coverage spreads.

Limited to investors tracking AI hardware supply chain; no immediate global macro effect.

Counterpoint

The targets are below consensus estimates; some may view the rating as overly cautious.

Key entities

  • Jefferies

    Equity research firm that initiated coverage with Buy ratings.

  • Nvidia

    Potential major customer referenced in the analyst thesis.

Related articles

$TERHigh

Teradyne's AI testing opportunity prompts Jefferies 'buy' rating

Jefferies initiated coverage of Teradyne (NYSE:TER) with a Buy rating and $284 price target, citing AI-driven demand. The broker forecasts semiconductor testing market growth to $25B by 2030, with Teradyne's SoC testing revenue rising to $6.9B. Teradyne's shares fell 53% from summer highs, which Jefferies sees as an entry point. The bank expects Teradyne to gain market share and benefit from Nvidia's (NASDAQ:NVDA) adoption of dual sourcing.

$FORMHigh

Why is FormFactor stock surging today?

FormFactor (FORM) stock rose 9.9% in pre-market trading after Jefferies initiated coverage with a Buy rating and $102 price target, citing a 47% discount from June highs. Jefferies forecasts 2027 revenue of $1.4B and 54% gross margins, driven by new Texas facility and AI-related demand. The surge follows broader tech sector gains and CoreWeave's strong earnings.

$TERHigh

Why is Teradyne stock surging today?

Teradyne (TER) stock rose 8% in pre-market trading after Jefferies initiated coverage with a Buy rating and $284 price target, citing AI-driven growth. Analysts expect the semiconductor test equipment market to expand significantly, with TER benefiting from increased system-on-chip testing. The company's Q3 2026 earnings beat consensus, and broader tech sector gains also supported the surge.